Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

IQV Iqvia Holdings Inc

Price (delayed)

$147.9

Market cap

$25.59B

P/E Ratio

19.96

Dividend/share

N/A

EPS

$7.41

Enterprise value

$38.35B

IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development ...

Highlights
The price to earnings (P/E) is 67% lower than the 5-year quarterly average of 60.0 and 26% lower than the last 4 quarters average of 26.9
IQV's revenue is up by 2.8% YoY
The quick ratio has decreased by 8% YoY
Iqvia Holdings's debt has increased by 6% YoY and by 2.5% from the previous quarter

Key stats

What are the main financial stats of IQV
Market
Shares outstanding
173M
Market cap
$25.59B
Enterprise value
$38.35B
Valuations
Price to earnings (P/E)
19.96
Price to book (P/B)
4.36
Price to sales (P/S)
1.68
EV/EBIT
16.56
EV/EBITDA
11.18
EV/Sales
2.47
Earnings
Revenue
$15.5B
Gross profit
$5.38B
Operating income
$2.19B
Net income
$1.33B
EBIT
$2.32B
EBITDA
$3.43B
Free cash flow
$2.19B
Per share
EPS
$7.41
EPS diluted
$7.33
Free cash flow per share
$12.45
Book value per share
$33.94
Revenue per share
$88.2
TBVPS
$44.35
Balance sheet
Total assets
$27.32B
Total liabilities
$21.34B
Debt
$14.51B
Equity
$5.98B
Working capital
-$1.27B
Liquidity
Debt to equity
2.43
Current ratio
0.82
Quick ratio
0.72
Net debt/EBITDA
3.72
Margins
EBITDA margin
22.1%
Gross margin
34.7%
Net margin
8.6%
Operating margin
14.1%
Efficiency
Return on assets
4.9%
Return on equity
20.7%
Return on invested capital
17.9%
Return on capital employed
11.5%
Return on sales
14.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IQV stock price

How has the Iqvia Holdings stock price performed over time
Intraday
3.59%
1 week
6.57%
1 month
-3.64%
1 year
-31.9%
YTD
-24.74%
QTD
-16.11%

Financial performance

How have Iqvia Holdings's revenue and profit performed over time
Revenue
$15.5B
Gross profit
$5.38B
Operating income
$2.19B
Net income
$1.33B
Gross margin
34.7%
Net margin
8.6%
IQV's operating income is up by 9% year-on-year
Iqvia Holdings's operating margin has increased by 5% YoY
Iqvia Holdings's net margin has decreased by 4.4% YoY and by 3.4% from the previous quarter
IQV's revenue is up by 2.8% YoY

Price vs fundamentals

How does IQV's price correlate with its fundamentals

Growth

What is Iqvia Holdings's growth rate over time

Valuation

What is Iqvia Holdings stock price valuation
P/E
19.96
P/B
4.36
P/S
1.68
EV/EBIT
16.56
EV/EBITDA
11.18
EV/Sales
2.47
The price to earnings (P/E) is 67% lower than the 5-year quarterly average of 60.0 and 26% lower than the last 4 quarters average of 26.9
IQV's EPS is down by 2.1% since the previous quarter
The stock's price to book (P/B) is 34% less than its 5-year quarterly average of 6.6 and 25% less than its last 4 quarters average of 5.8
The equity has contracted by 6% YoY
The stock's price to sales (P/S) is 40% less than its 5-year quarterly average of 2.8 and 30% less than its last 4 quarters average of 2.4
IQV's revenue is up by 2.8% YoY

Efficiency

How efficient is Iqvia Holdings business performance
The company's return on invested capital rose by 10% YoY
The ROE has decreased by 8% YoY
IQV's return on assets is down by 6% year-on-year and by 3.9% since the previous quarter
IQV's return on sales is up by 4.9% year-on-year

Dividends

What is IQV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IQV.

Financial health

How did Iqvia Holdings financials performed over time
The total assets is 28% greater than the total liabilities
The quick ratio has decreased by 8% YoY
Iqvia Holdings's current ratio has decreased by 7% YoY and by 2.4% from the previous quarter
Iqvia Holdings's debt is 143% more than its equity
The debt to equity has increased by 12% YoY and by 4.3% from the previous quarter
Iqvia Holdings's debt has increased by 6% YoY and by 2.5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.